Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell–Specific Gene Promoters
Tereza Andreou(University of Leeds), Mihaela Lorger(University of Leeds), Christopher M. Fife(St James's University Hospital), Teklu Egnuni(University of Leeds), Jennifer M. Williams(South African Medical Research Council), Krzysztof Wronski, Ashley Sunderland(University of Leeds), Sheri L. Holmen(University of Utah), Stéphanie Cherqui(University of California San Diego), Nora Rippaus(University of Leeds), Ryan Mathew(Leeds Teaching Hospitals NHS Trust), David J. Taggart(ID Genomics (United States)), Rebecca J. Brownlie(University of Leeds), Alastair Droop(Wellcome Sanger Institute), Yolanda D Kartika(University of Leeds)
Cited by 24
Related Papers
Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis
|American Journal Of Pathology|2010|353
Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa
|Nature Communications|2018|239
Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8 <sup>+</sup> T cell trafficking
|Proceedings of the National Academy of Sciences|2018|209
Activation of tumor cell integrin α <sub>v</sub> β <sub>3</sub> controls angiogenesis and metastatic growth in the brain
|Proceedings of the National Academy of Sciences|2009|185
Distinct cell-specific control of autoimmunity and infection by FcγRIIb
|The Journal of Experimental Medicine|2008|164